NEW YORK, Aug. 12 (UPI) -- Former ImClone Systems Inc. boss Samuel Waksal pleaded innocent Monday to charges of insider trading. Waksal faces 13 charges of insider trading, including for conspiracy, fraud and obstruction of justice, in connection with the company's cancer drug, Erbitux.
Advertisement